Literature DB >> 23399903

Electrodiagnostic testing and histopathologic changes confirm peripheral nervous system myelin abnormalities in the feline model of niemann-pick disease type C.

Jessica H Bagel1, Tracey U Sikora, Maria Prociuk, Jill P Pesayco, Andrew P Mizisin, G Diane Shelton, Charles H Vite.   

Abstract

Niemann-Pick disease type C (NPC disease) is an incurable, neurodegenerative, autosomal recessive disease caused by mutations in either the NPC1 or the NPC2 gene. These mutations affect the intracellular trafficking of lipids and cholesterol, resulting in the intralysosomal accumulation of unesterified cholesterol and glycosphingolipids. These abnormalities are associated with clinical ataxia and impaired motor and intellectual development, and death frequently occurs in adolescence. The incidence of peripheral neuropathy in NPC patients is not known. We investigated peripheral nerves in the naturally occurring feline model of NPC disease, which has proven to be critical for understanding both disease pathogenesis and for evaluating experimental therapies. Electrodiagnostic studies revealed significantly slowed motor and sensory nerve conduction velocities in affected cats in the absence of altered M-wave amplitude. Histologic and ultrastructural analyses showed thin myelin sheaths, membranous debris, myelin figures, lipid vacuolization of Schwann cell cytoplasm, and expanded paranodal areas. Axonal degeneration was not identified. There was a shift to small myelinated fibers in affected cats, and there were significant decreases in fiber diameter, axon diameter, and myelin thickness. These changes were similar to those described in the murine NPC disease model and in rare patients in whom nerve biopsy has been performed. Characterization of the demyelinating neuropathy is necessary for evaluating clinical trials that target only the CNS aspects of NPC.

Entities:  

Mesh:

Year:  2013        PMID: 23399903      PMCID: PMC3640270          DOI: 10.1097/NEN.0b013e318286587f

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  31 in total

Review 1.  Niemann-Pick type C: a disorder of cellular cholesterol trafficking.

Authors:  D S Ory
Journal:  Biochim Biophys Acta       Date:  2000-12-15

2.  Decreased expression of myelin gene regulatory factor in Niemann-Pick type C 1 mouse.

Authors:  Xin Yan; Jan Lukas; Martin Witt; Andreas Wree; Rayk Hübner; Moritz Frech; Rüdiger Köhling; Arndt Rolfs; Jiankai Luo
Journal:  Metab Brain Dis       Date:  2011-09-21       Impact factor: 3.584

3.  Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.

Authors:  Benny Liu
Journal:  Clin Lipidol       Date:  2012-06

4.  Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations.

Authors:  M Zervas; K Dobrenis; S U Walkley
Journal:  J Neuropathol Exp Neurol       Date:  2001-01       Impact factor: 3.685

5.  NT-3 attenuates functional and structural disorders in sensory nerves of galactose-fed rats.

Authors:  A P Mizisin; M W Kalichman; M Bache; K C Dines; P S DiStefano
Journal:  J Neuropathol Exp Neurol       Date:  1998-09       Impact factor: 3.685

6.  Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination.

Authors:  Ben Emery; Dritan Agalliu; John D Cahoy; Trent A Watkins; Jason C Dugas; Sara B Mulinyawe; Adilijan Ibrahim; Keith L Ligon; David H Rowitch; Ben A Barres
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

Review 7.  Niemann-Pick disease type C.

Authors:  M T Vanier; G Millat
Journal:  Clin Genet       Date:  2003-10       Impact factor: 4.438

8.  Neurological manifestations of Niemann-Pick disease type C in cats.

Authors:  K R Muñana; P J Luttgen; M A Thrall; T W Mitchell; D A Wenger
Journal:  J Vet Intern Med       Date:  1994 Mar-Apr       Impact factor: 3.333

9.  Clinical, electrophysiological, and serum biochemical measures of progressive neurological and hepatic dysfunction in feline Niemann-Pick type C disease.

Authors:  Charles H Vite; Wenge Ding; Caroline Bryan; Patricia O'Donnell; Karyn Cullen; David Aleman; Mark E Haskins; Thomas Van Winkle
Journal:  Pediatr Res       Date:  2008-11       Impact factor: 3.756

10.  Niemann-Pick type C disease associated with peripheral neuropathy.

Authors:  Dimitrios I Zafeiriou; Panagiota Triantafyllou; Nikolaos P Gombakis; Euthymia Vargiami; Chaido Tsantali; Eleni Michelakaki
Journal:  Pediatr Neurol       Date:  2003-09       Impact factor: 3.372

View more
  12 in total

1.  PMP22 Regulates Cholesterol Trafficking and ABCA1-Mediated Cholesterol Efflux.

Authors:  Ye Zhou; Joshua R Miles; Hagai Tavori; Min Lin; Habibeh Khoshbouei; David R Borchelt; Hannah Bazick; Gary E Landreth; Sooyeon Lee; Sergio Fazio; Lucia Notterpek
Journal:  J Neurosci       Date:  2019-05-06       Impact factor: 6.167

2.  Synaptic failure: The achilles tendon of sphingolipidoses.

Authors:  Ludovico Cantuti-Castelvetri; Ernesto R Bongarzone
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II.

Authors:  Junjie Hong; Yu-Shan Cheng; Shu Yang; Manju Swaroop; Miao Xu; Jeanette Beers; Jizhong Zou; Wenwei Huang; Juan J Marugan; Xiujun Cai; Wei Zheng
Journal:  Exp Cell Res       Date:  2022-01-04       Impact factor: 3.905

Review 4.  Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.

Authors:  Paul Helquist; Frederick R Maxfield; Norbert L Wiech; Olaf Wiest
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

5.  Electrophysiologic confirmation of heterogenous motor polyneuropathy in young cats.

Authors:  M Aleman; P J Dickinson; D C Williams; B K Sturges; R A LeCouteur; K M Vernau; G D Shelton
Journal:  J Vet Intern Med       Date:  2014-09-17       Impact factor: 3.333

6.  Precision Medicine in Cats: Novel Niemann-Pick Type C1 Diagnosed by Whole-Genome Sequencing.

Authors:  D A Mauler; B Gandolfi; C R Reinero; D P O'Brien; J L Spooner; L A Lyons
Journal:  J Vet Intern Med       Date:  2017-02-24       Impact factor: 3.333

Review 7.  Canine and Feline Models of Human Genetic Diseases and Their Contributions to Advancing Clinical Therapies
.

Authors:  Brittney L Gurda; Allison M Bradbury; Charles H Vite
Journal:  Yale J Biol Med       Date:  2017-09-25

Review 8.  Understanding and Treating Niemann-Pick Type C Disease: Models Matter.

Authors:  Valentina Pallottini; Frank W Pfrieger
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

9.  Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats.

Authors:  T Bucher; L Dubreil; M-A Colle; M Maquigneau; J Deniaud; M Ledevin; P Moullier; B Joussemet
Journal:  Gene Ther       Date:  2014-02-27       Impact factor: 5.250

Review 10.  Current Challenges in Understanding the Cellular and Molecular Mechanisms in Niemann-Pick Disease Type C1.

Authors:  Anja U Bräuer; Angela Kuhla; Carsten Holzmann; Andreas Wree; Martin Witt
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.